HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Wanscher Selected Research

Interleukin-6 (Interleukin 6)

12/2017Level of systemic inflammation and endothelial injury is associated with cardiovascular dysfunction and vasopressor support in post-cardiac arrest patients.
1/2016Predictive value of interleukin-6 in post-cardiac arrest patients treated with targeted temperature management at 33 °C or 36 °C.
6/2015Systemic Inflammatory Response and Potential Prognostic Implications After Out-of-Hospital Cardiac Arrest: A Substudy of the Target Temperature Management Trial.
6/2012Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity.
4/2012High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Wanscher Research Topics

Disease

40Out-of-Hospital Cardiac Arrest
11/2021 - 04/2012
20Coma (Comas)
11/2021 - 12/2012
18Heart Arrest (Cardiac Arrest)
10/2022 - 01/2009
8Inflammation (Inflammations)
11/2020 - 01/2011
6Hypothermia
12/2017 - 09/2012
5Shock
01/2015 - 01/2011
4Wounds and Injuries (Trauma)
01/2014 - 01/2011
3Hemorrhage
11/2022 - 09/2013
3Brain Injuries (Brain Injury)
01/2021 - 07/2015
2Sepsis (Septicemia)
01/2017 - 04/2012
2Pneumonia (Pneumonitis)
01/2017 - 07/2015
2Bradycardia
02/2016 - 04/2015
2Thrombosis (Thrombus)
11/2015 - 01/2011
1Postoperative Cognitive Complications
01/2022
1Infarction (Infarctions)
01/2021
1Post-Cardiac Arrest Syndrome
11/2020
1Acute Kidney Injury (Acute Renal Failure)
12/2019
1Low Cardiac Output
12/2019
1Septic Shock (Toxic Shock Syndrome)
01/2017
1Atrial Fibrillation
12/2016
1Brain Diseases (Brain Disorder)
10/2016
1Mannose-Binding Protein Deficiency
04/2016
1Stroke (Strokes)
04/2016
1Ischemia
04/2016
1Myocardial Infarction
11/2015
1Cardiogenic Shock
02/2015
1ST Elevation Myocardial Infarction
01/2015
1Fever (Fevers)
12/2013
1Cardiac Arrhythmias (Arrythmia)
09/2013
1Infections
09/2013
1Seizures (Absence Seizure)
09/2013
1Tics (Tic)
01/2011
1Disseminated Intravascular Coagulation
01/2011

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2011
6Phosphopyruvate Hydratase (Enolase)IBA
10/2022 - 05/2015
5Interleukin-6 (Interleukin 6)IBA
12/2017 - 04/2012
4ThrombomodulinIBA
01/2015 - 01/2011
3Fibrinogen (Factor I)FDA Link
11/2022 - 01/2011
3Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2021 - 04/2012
3Lactic Acid (Lactate)FDA LinkGeneric
12/2019 - 09/2014
3Protein CIBA
06/2012 - 01/2011
3Syndecan-1 (Syndecan 1)IBA
06/2012 - 01/2011
3fibrin fragment D (D-dimer)IBA
06/2012 - 01/2011
3Histones (Histone)IBA
06/2012 - 01/2011
3DNA (Deoxyribonucleic Acid)IBA
06/2012 - 01/2011
3Plasminogen Activator Inhibitor 1IBA
06/2012 - 01/2011
3Endothelial Protein C ReceptorIBA
06/2012 - 01/2011
3Tissue Plasminogen Activator (Alteplase)FDA Link
06/2012 - 01/2011
2Calcium-Binding ProteinsIBA
10/2022 - 12/2017
2Glial Fibrillary Acidic ProteinIBA
01/2022 - 01/2020
2ProcalcitoninIBA
01/2017 - 06/2015
2Protein SIBA
06/2012 - 01/2011
2lipoprotein-associated coagulation inhibitor (TFPI)IBA
06/2012 - 01/2011
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
06/2012 - 01/2011
2Epinephrine (Adrenaline)FDA LinkGeneric
06/2012 - 04/2012
2von Willebrand FactorIBA
06/2012 - 04/2012
2Annexin A5IBA
06/2012 - 01/2011
2AntithrombinsIBA
06/2012 - 01/2011
1Complement System Proteins (Complement)IBA
11/2020
1Proteins (Proteins, Gene)FDA Link
11/2020
1LectinsIBA
11/2020
1Ubiquitin CIBA
01/2020
1S100 Proteins (S 100 Protein)IBA
01/2017
1C-Reactive ProteinIBA
01/2017
1pro-brain natriuretic peptide (1-76)IBA
10/2016
1Brain Natriuretic Peptide (Natrecor)FDA Link
10/2016
1Iron-Dextran Complex (InFed)FDA Link
09/2016
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
04/2016
1Neuroprotective AgentsIBA
11/2015
1Anti-Bacterial Agents (Antibiotics)IBA
07/2015
1A 17 (A-17)IBA
04/2015
1ElectrolytesIBA
09/2013
1cytidylyl-(3'-5')-cytidine (CpC)IBA
09/2013
1prothrombin fragment 1.2IBA
06/2012
1CD40 Ligand (CD40L)IBA
06/2012
1Factor XIII (Coagulation Factor XIII)IBA
06/2012
1antithrombin III-protease complexIBA
06/2012
1AntigensIBA
04/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2012
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2012
1Angiopoietin-2IBA
04/2012
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2011
1ThrombinFDA Link
01/2011
1Dacarbazine (DIC)FDA LinkGeneric
01/2011
1InterleukinsIBA
01/2011
1Hemostatics (Antihemorrhagics)IBA
01/2011

Therapy/Procedure

35Induced Hypothermia
11/2021 - 04/2012
11Resuscitation
12/2019 - 01/2009
4Therapeutics
01/2018 - 02/2015
3Percutaneous Coronary Intervention
08/2018 - 12/2012
3Cardiopulmonary Resuscitation (CPR)
01/2018 - 11/2014
3Rewarming
01/2017 - 04/2016
3Cannula
01/2014 - 01/2011
1Operative Time
11/2022
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2021
1Extracorporeal Membrane Oxygenation
09/2016
1Stents
11/2015
1Home Nursing (Nursing, Home)
03/2014
1Renal Replacement Therapy (Therapies, Renal Replacement)
09/2013